Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest Angiotech Pharmaceuticals Inc. Stories

2011-10-21 07:00:00

VANCOUVER, Oct. 21, 2011 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. today announced changes to its senior management team.  Dr. William Hunter will no longer serve as Angiotech's President and CEO, and Thomas Bailey, Angiotech's Chief Financial Officer, will serve as Angiotech's interim President and CEO.  Angiotech also announced today that Tammy Neske has been promoted to Chief Business Officer, and Steven Bryant and Victor Diaz have each been promoted to the position...

2011-08-09 20:44:00

VANCOUVER, Aug. 9, 2011 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. today announced that it released its financial results for the second quarter ended June 30, 2011. As announced previously, Angiotech will host a conference call discussing its second quarter financial results on Thursday, August 11, 2011 at 11:00 AM ET (8:00 AM PT). Details regarding the conference call can be found on Angiotech's website at www.angiotech.com. Financial Information This press...

2011-08-03 13:00:00

Second Quarter 2011 Financial Results VANCOUVER, Aug. 3, 2011 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the second quarter ended June 30, 2011, on Thursday, August 11, 2011 at 11:00 AM ET (8:00 AM PT). Dial-in information for the earnings call on August 11, 2011 is as follows: North America(toll-free): (866) 783-2140 International: (857) 350-1599...

2011-05-20 13:00:00

First Quarter 2011 Financial Results VANCOUVER, May 20, 2011 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the first quarter ended March 31, 2011, on Thursday, May 26, 2011 at 11:00 AM ET (8:00 AM PT). Dial-in information for the earnings call on May 26, 2011 is as follows: North America(toll-free): (800) 638-5439 International: (617)...

2011-05-12 17:30:00

VANCOUVER, May 12 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ("Angiotech" or the "Company") announced today that, together with certain of its Canadian and United States subsidiaries (collectively, the "Angiotech Entities"), it has successfully implemented the second amended and restated plan of compromise or arrangement (as amended, the "Amended Plan") under the Companies' Creditors Arrangement Act (Canada) (the "CCAA") as previously approved by the Supreme Court of...

2011-04-28 21:00:00

VANCOUVER, April 28 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ("Angiotech" or the "Company") today announced that it has extended its offer (the "Exchange Offer") to exchange new senior secured floating rate notes due 2013 (the "New Floating Rate Notes") for all of its outstanding Senior Floating Rate Notes due 2013 (the "Existing Floating Rate Notes") to 12:00 a.m. New York City time on May 12, 2011.  The Exchange Offer was last scheduled to expire at 11:59 p.m....

2011-04-22 20:00:00

VANCOUVER, April 22 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ("Angiotech" or the "Company") announced today that it has reached an agreement (the "Sixth Extension Agreement") with the holders of a majority of the principal amount outstanding of the Company's 7.75% Senior Subordinated Notes (the "Subordinated Notes") to extend, to May 12, 2011, the date by which implementation of the previously announced recapitalization transaction must take place pursuant to the...

2011-04-04 22:01:00

VANCOUVER, April 4 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ("Angiotech" or the "Company") today announced that the affected creditors of Angiotech and certain of its subsidiaries (collectively, the "Angiotech Entities") have unanimously approved the Second Amended and Restated Plan of Compromise or Arrangement (as amended from time to time, the "Amended Plan") concerning, affecting and involving the Angiotech Entities pursuant to the Companies' Creditors Arrangement...

2011-02-18 14:00:00

Angiotech Authorized to Hold a Meeting of Affected Creditors VANCOUVER, Feb. 18 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (TSX: ANP) ("Angiotech" or the "Company") today announced that the Supreme Court of British Columbia (the "Court") has accepted for filing a plan of compromise or arrangement (the "Plan"), with terms and conditions materially consistent with Angiotech's previously announced recapitalization transaction, relating to Angiotech and certain of its...

2011-02-11 11:30:00

VANCOUVER, Feb. 11 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ("Angiotech" or the "Company") announced that the Company and certain of its subsidiaries have entered into a definitive agreement with Wells Fargo Capital Finance LLC ("Wells Fargo") in respect of the previously announced debtor-in-possession credit facility ("DIP Facility").  The DIP Facility will provide liquidity for working capital, general corporate purposes and expenses while the Company implements...